36 Biggest Movers From Yesterday

Gainers

• Bit Digital, Inc. BTBT shares climbed 36.4% to settle at $10.35 on Tuesday amid an increase in the price of Bitcoin and Ethereum.
• Zeta Global Holdings Corp. ZETA surged 30.5% to close at $8.22. Zeta reported the acquisition of the technology platform and data from Apptness.
• Marine Petroleum Trust MARPS shares surged 20.2% to close at $6.13 on Tuesday after gaining 8% on Monday.
• Navios Maritime Holdings Inc. NM climbed 16% to settle at $5.86.
• SmileDirectClub, Inc. SDC surged 15.6% to close at $5.87. SmileDirectClub said the United States Patent & Trademark Office will issue a patent on the company’s innovative SmileBus concept.
• Otonomo Technologies Ltd. OTMO surged 15.1% to settle at $5.73. Otonomo announced the acquisition of Neura.
• Synaptogenix, Inc. SNPX gained 13.9% to close at $9.99.
• Elite Education Group International Limited EEIQ gained 13.3% to close at $4.42 after the company said, as of Sept. 30, 2021, indicators of recruitment, enrollment for its English language program at regional campuses of Miami University of Ohio were better than those for period ended Sept. 30, 2020.
• ACM Research, Inc. ACMR gained 12.6% to close at $117.70.
• Silvergate Capital Corporation SI surged 12.6% to settle at $153.00.
• MediaAlpha, Inc. MAX gained 11.9% to close at $18.58.
• Shineco, Inc. TYHT climbed 11.4% to close at $11.65. Shineco agreed to acquire 51% equity interest of Beijing Wonner Biotech.
• Icosavax, Inc. ICVX gained 10.5% to settle at $32.05.
• Rush Street Interactive, Inc. RSI rose 7.8% to close at $20.17.
• Team, Inc. TISI rose 6.8% to close at $3.46 after the company said it won a multi-year upstream mechanical inspection and integrity contract from Chevron.
• Hyzon Motors Inc. HYZN gained 6.5% to close at $6.39. Hyzon Motors issued response to recent short seller report.
• ZIOPHARM Oncology, Inc. ZIOP rose 6.2% to settle at $1.89. Ziopharm Oncology Director Jamie Vieser reported the purchase of 100,000 shares at an average price of $1.91 in form 4 filing.

Check out these big penny stock gainers and losers

Losers

• Camber Energy, Inc. CEI shares tumbled 50.5% to settle at $1.53 after Kerrisdale Capital issued a short report on the company.
• UpHealth, Inc. UPH shares dropped 36% to close at $1.67 on Tuesday after the company reported pricing of $40.25 million public offering of common stock.
• Mexco Energy Corporation MXC fell 28.1% to settle at $12.21 after jumping 46% on Monday.
• DatChat, Inc. DATS dropped 23.9% to close at $8.90.
• MediaCo Holding Inc. MDIA fell 23.3% to close at $8.13.
• Salem Media Group, Inc. SALM dipped 22.2% to settle at $3.48.
• OpGen, Inc. OPGN dropped 19.1% to close at $2.38. OpGen shares gained over 6% on Monday after the company announced it received FDA clearance for Acuitas AMR gene panel.
• Huadi International Group Co., Ltd. HUDI declined 16.6% to close at $3.31.
• Roivant Sciences Ltd. ROIV fell 16.1% to close at $6.82 after dropping 13% on Monday.
• DICE Therapeutics, Inc. DICE dropped 14.5% to settle at $27.64.
• Nuvalent, Inc. NUVL fell 14.2% to close at $21.30.
• Jasper Therapeutics, Inc. JSPR dropped 13.7% to close at $8.00. Amgen recently showed a 2.7M share ownership stake in the company in a SEC filing.
• PEDEVCO Corp. PED shares declined 12.6% to close at $1.66. PEDEVCO shares dropped 10% on Monday after the company announced it would sell $7 million of stock to an institutional investor for $1.57 per share.
• InnSuites Hospitality Trust IHT dipped 11.6% to close at $3.65.
• Lordstown Motors Corp. RIDE fell 11.1% to close at $5.20 after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and lowered its price target from $8 to $2.
• Comtech Telecommunications Corp. CMTL dipped 10.8% to close at $22.63 after reporting quarterly results. Noble Capital Markets downgraded Comtech from Outperform to Market Perform.
• Kaleido Biosciences, Inc. KLDO shares fell 9.6% to close at $5.26. Kaleido Biosciences announced positive topline data from the non-IND/CTA clinical study evaluating KB295, a microbiome metabolic therapy, in mild-to-moderate ulcerative colitis.
• Sylvamo Corporation SLVM dropped 7.5% to close at $25.90 after declining 15% on Monday.
• Unity Biotechnology, Inc. UBX dropped 4.3% to close at $2.66. UNITY Biotechnology reported 12-week data from Phase 1 clinical trial of UBX1325 in advanced vascular eye disease.